Federal contract award
75F40122C00196
BAA EETWP #63: A STANDARDIZED FRAMEWORK TO SUPPORT FDA QUALIFICATION OF COMPLEX IN VITRO MODELS FOR USE IN REGULATORY SUBMISSIONS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $1.7M |
| Current contract value | $1.7M |
| Potential contract value / ceiling | $1.7M |
| Start date | Sep 26, 2022 |
| Current end date | Apr 17, 2025 |
| Potential end date | May 28, 2025 |
| Latest award activity | May 11, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 11, 2026 | P00008 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO CANCEL NON-FUNDED ITEMS 3, 5, 6, 7, 8 AND CLOSE OUT THE CONTRACT. |
| Feb 19, 2026 | P00007 | $-712.5K | TERMINATION SETTLEMENT MODIFICATION |
| Apr 17, 2025 | P00006 | $0 | EOI:: GSA WASTEFUL SPENDING ::EOI FULL TERMINATION FOR CONVENIENCE |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.